Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene

Diabetes

Volumn 50, Issue 5, 2001, Pages 1143-1148

  Stefan, Norbert ^a   Fritsche, Andreas ^a   Häring, Hans ^a   Stumvoll, Michael ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; C PEPTIDE; FATTY ACID; GLUCOSE; HEPARIN; INTRALIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ADULT; ARTICLE; CODON; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0035032780     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.5.1143     Document Type: Article

References (36)

1. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
2. PPARγ, the ultimate thrifty gene
3. 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
4. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
5. PPAR-γ: Adipogenic regulator and thiazolidinedione receptor
6. Expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in normal human pancreatic islet cells
7. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
8. The PPARγ2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects
9. Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes
10. Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2): Divergent modulating effects on body mass index in obese and lean Caucasian men
11. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations
12. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women
13. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans
14. The common PPAR gamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
15. Interactions between glucose and FFA metabolism in man
16. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
17. Effects of a 48-h fat infusion on insulin secretion and glucose utilization
18. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans
19. Mechanisms of fatty acid-induced inhibition of glucose uptake
20. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans
21. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemic clamp
22. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM
23. Role of non-esterified fatty acids in the pathogenesis of type 2 diabetes mellitus
24. Cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
25. Estimation of insulin secretion rates from C-peptide levels: Comparison of individual and standard kinetic parameters for C-peptide clearance
26. Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion
27. Characterisation of beta-cell dysfunction of impaired glucose tolerance: Evidence for impairment of incretin-induced insulin secretion
28. Fatty acids, lipotoxicity and insulin secretion
29. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation
30. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma
31. Altered gene expression for tumor necrosis factor-α and its receptor during drug and dietary modulation of insulin resistance
32. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: Implications for the development of adipogenic diabetes mellitus
33. Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and amino-guanidine: A role for peroxisome proliferator-activated receptor gamma activation and inos expression
34. Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-γ2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-α gene expression in human subcutaneous adipose tissue
35. Induction of the acylcoenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter
36. Glucose clamp technique: A method for quantifying insulin secretion and resistance